ContributorsPublishersAdvertisers

Sotorasib Earns Approval in Japan for KRAS G12C+ NSCLC

cancernetwork.com
 2022-01-20

Cover picture for the articleThe Japan Ministry of Health, Labour and Welfare granted approval to the KRAS inhibitor sotorasib for the treatment of adults with KRAS G12C–mutated non–small cell lung cancer. Patients with KRAS G12C–positive unresectable, advanced, or recurrent non–small cell lung cancer (NSCLC) who have received prior therapy can now...

www.cancernetwork.com

Comments / 0

Comments / 0